Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$734M |
| 2 |
Adobe
ADBE
|
+$488M |
| 3 |
Merck
MRK
|
+$443M |
| 4 |
Tesla
TSLA
|
+$366M |
| 5 |
AGN
Allergan plc
AGN
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$682M |
| 2 |
Perrigo
PRGO
|
+$585M |
| 3 |
Gilead Sciences
GILD
|
+$556M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$432M |
| 5 |
Morgan Stanley
MS
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.94% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Communication Services | 11.27% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
McKesson
MCK
$104B
| $23.7M | 0.02% |
+146,686
| New | +$22.5M |
|
|
LPNT
427
DELISTED
LifePoint Health, Inc.
LPNT
| $23.3M | 0.02% |
441,126
-13,997
| -3% | -$703K |
|
428
Chefs' Warehouse
CHEF
$4.31B
| $23.1M | 0.02% |
791,129
-34,753
| -4% | -$867K |
|
|
TAHO
429
DELISTED
Tahoe Resources Inc
TAHO
| $22.3M | 0.02% |
1,341,557
+1,259
| +0.1% | +$22.1K |
|
|
DFRG
430
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $22.3M | 0.02% |
945,847
+287,365
| +44% | +$5.76M |
|
|
ATMI
431
DELISTED
A T M I INC
ATMI
| $22.1M | 0.02% |
732,881
-1,368,246
| -65% | -$39.1M |
|
432
Prothena Corp
PRTA
$448M
| $22.1M | 0.02% |
833,855
+341,761
| +69% | +$8.57M |
|
433
RH
RH
$3.33B
| $21.9M | 0.02% |
+325,365
| New | +$22.3M |
|
434
Moog Inc Class A
MOG.A
$12.4B
| $21.9M | 0.02% |
321,763
-43,395
| -12% | -$2.73M |
|
|
CLDT
435
Chatham Lodging
CLDT
$632M
| $21.8M | 0.02% |
1,067,660
-65,785
| -6% | -$1.3M |
|
|
ENDP
436
DELISTED
Endo International plc
ENDP
| $21.8M | 0.02% |
323,167
+32,963
| +11% | +$1.88M |
|
|
SUSS
437
DELISTED
SUSSER HOLDINGS CORPORATION COMMON STOCK
SUSS
| $21.6M | 0.02% |
329,570
-126,060
| -28% | -$7.46M |
|
438
BOK Financial
BOKF
$8.58B
| $21.6M | 0.02% |
325,262
-299,537
| -48% | -$18.9M |
|
439
Artisan Partners
APAM
$2.86B
| $21.4M | 0.02% |
327,822
-6,180
| -2% | -$368K |
|
440
Zurn Elkay Water Solutions
ZWS
$8.6B
| $21.2M | 0.02% |
1,630,603
-128,319
| -7% | -$1.45M |
|
441
Southern Copper
SCCO
$138B
| $21M | 0.02% |
788,225
-24,550
| -3% | -$616K |
|
442
B2Gold
BTG
$4.98B
| $21M | 0.02% |
10,220,886
+10,865
| +0.1% | +$24.2K |
|
443
Madrigal Pharmaceuticals
MDGL
$12.6B
| $20.8M | 0.02% |
113,161
-12,203
| -10% | -$2.23M |
|
|
TIVO
444
DELISTED
Tivo Inc
TIVO
| $20.5M | 0.02% |
+1,041,910
| New | +$19.1M |
|
445
Insulet
PODD
$11.8B
| $20.4M | 0.02% |
548,680
-1,455,527
| -73% | -$53.8M |
|
|
IRF
446
DELISTED
INTL RECTIFIER CORP
IRF
| $20.2M | 0.02% |
775,374
-465,473
| -38% | -$11.3M |
|
447
Mercado Libre
MELI
$94.5B
| $20.1M | 0.02% |
186,401
-3,848
| -2% | -$461K |
|
|
CIM
448
Chimera Investment
CIM
$1.06B
| $19.8M | 0.02% |
425,039
-16,497
| -4% | -$751K |
|
|
RALY
449
DELISTED
RALLY SOFTWARE DEV CORP
RALY
| $19.3M | 0.02% |
993,259
+488,858
| +97% | +$11.9M |
|
450
Dover
DOV
$26.7B
| $18.8M | 0.02% |
290,580
-36,972
| -11% | -$2.26M |
|
Similar funds
Jennison Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Jennison Associates held 759 positions worth $102B, up 6.9% from $95.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q4 2013 filing shows 79 new, 184 increased, 411 reduced and 54 closed positions. Its largest new stake was Allergan plc: 2,016,619 shares worth $339M. The largest sale was UnitedHealth, an estimated $682M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2013 buy was Allergan plc: 2,016,619 shares worth $339M.
- Jennison Associates added most to Bristol-Myers Squibb in Q4 2013, an estimated $734M increase.
- Jennison Associates's biggest Q4 2013 reduction was UnitedHealth, cutting an estimated $682M.
- Jennison Associates fully exited Perrigo in Q4 2013, selling an estimated $585M.
- Jennison Associates's ten largest holdings make up 20% of its $102B portfolio in Q4 2013.
- Jennison Associates opened 79 new positions and closed 54 in Q4 2013.
- Jennison Associates's portfolio value rose 6.9% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.